Diagnostik und Therapie der chronischen Nierenerkrankung-Reference-Cited by-同舟云学术

Diagnostik und Therapie der chronischen Nierenerkrankung

Published:2017-02-13 Issue:3 Volume:58 Page:243-256
ISSN:0020-9554
Container-title:Der Internist
language:de
Short-container-title:Internist

Author:

Girndt M.

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00108-017-0195-2.pdf

Reference33 articles.

1. KDIGO (2013) Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1

2. Inker LA et al (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367:20–29

3. Girndt M et al (2016) Prävalenz der eingeschränkten Nierenfunktion. Bevölkerungsrepräsentative Studie von 2008–2011 zur Gesundheit Erwachsener in Deutschland (DEGS1). Dtsch Arztebl 113:85–91

4. Titze S et al (2015) Disease burden and risk profile in referred patients with moderate chronic kidney disease: Composition of the German Chronic Kidney Disease (GCKD) cohort. Nephrol Dial Transplant 30:441–451

5. Eriksen BO, Ingebretsen OC (2006) The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age. Kidney Int 69:375–382

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning assessment of vildagliptin and linagliptin effectiveness in type 2 diabetes: Predictors of glycemic control;PLOS ONE;2024-08-26

2. GDH1 exacerbates renal fibrosis by inhibiting the transcriptional activity of peroxisome proliferator‐activated receptor gamma;The FEBS Journal;2024-08-13

3. Evaluating the therapeutic effects of NiaoDuQing particles on chronic kidney disease based on real world study;Technology and Health Care;2024-07-28

4. Impact of Bioactive Compounds in the Management of Various Inflammatory Diseases;Current Pharmaceutical Design;2024-07

5. Predictors of major adverse lower limb events in patients with tissue loss secondary to critical limb-threatening ischemia;Cardiovascular Revascularization Medicine;2024-02